Antiproliferative effects of calcitonin gene-related peptide in aortic and pulmonary artery smooth muscle cells

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 288, Issue 1 32-1, 2005, Pages

  Chattergoon, N N ^a   D'Souza, F M ^a   Deng, W ^a   Chen, H ^a   Hyman, A L ^a   Kadowitz, P J ^a   Jeter Jr , J R ^a,b  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Dept of Struct/Cell Biol SL 49 ^*  (United States)

Author keywords

Adenovirus; Nitric oxide; Vascular smooth muscle cells

Indexed keywords

ADENOVIRUS VECTOR; CALCITONIN GENE RELATED PEPTIDE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; NITRIC OXIDE; PROTEIN P21; PROTEIN P53;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; AORTA MEDIA; ARTICLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENETIC TRANSFECTION; IN VITRO STUDY; LUNG ARTERY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PULMONARY HYPERTENSION; RAT; SMOOTH MUSCLE FIBER; VASODILATATION;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ANIMALS; AORTA; CALCITONIN GENE-RELATED PEPTIDE; CELL DIVISION; CELLS, CULTURED; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; ENZYME INHIBITORS; MALE; MYOCYTES, SMOOTH MUSCLE; PULMONARY ARTERY; RATS; RATS, SPRAGUE-DAWLEY; THIONUCLEOTIDES; TRANSFECTION;

EID: 11144310596     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00064.2004     Document Type: Article

References (39)

1. Aiyar N, Disa J, and Nambi P. CGRP receptors, structure and function. In: The CGRP Family: Calcitonin Gene-Related Peptide (CGRP), Amylin, and Adrenomedullin, edited by Poyner D, Marshall I, and Brain S. Georgetown, Texas: Eurekah.com/Landes Bioscience, 2000, p. 43-53.
2. Amara SG, Jonas V, and Rosenfeld MG. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature 298: 240-244, 1982.
3. Arroliga AC, Matthay MA, and Matthay RA. Pulmonary thromboembolism and other pulmonary vascular diseases. In: Chest Medicine: Essentials of Pulmonary and Critical Care Medicine, edited by George RB. Baltimore, MD: Lippincott Williams & Wilkins, 2000, p. 247-251.
4. Bornfeldt KE and Krebs EG. Crosstalk between protein kinase A and growth factor receptor signaling pathways in arterial smooth muscle. Cell Signal 11:465-477, 1999.
5. Boyer JC, Christen MO, Balmes JL, and Bali JP. Calcitonin gene-related peptide-induced relaxation of isolated human colonic smooth muscle cells through different intracellular pathways. Biochem Pharmacol 56; 1097-1104, 1998.
6. Brain SD, Williams TJ, Tippins JR, Morris HR, and MacIntyre I. Calcitonin gene-related peptide is a potent vasodilator. Nature 313: 54-56, 1985.
7. Champion HC, Bivalacqua TJ, D'Souza FM, Ortiz LA, Jeter JH, Toyoda K, Heistad DD, Hyman AL, and Kadowitz PJ. Gene transfer of endothelial nitric oxide synthase to the lung of the mouse-in vivo. Circ Res 84: 1422-1432, 1999.
8. Champion HC, Bivalacqua TJ, Pierce RL, Murphy WA, Coy DH, Hyman AL, and Kadowitz PJ. Responses to human CGRP, ADM, and PAMP in human thymic arteries. Am J Physiol Regul Integr Comp Physiol 284: R531-R537, 2003.
9. Champion HC, Bivalacqua TJ, Toyoda K, Heistad DD, Hyman AL, and Kadowtiz PJ. In vivo gene transfer of prepro-calcitonin gene-related peptide to the lung attenuates chronic hypoxia-induced pulmonary hypertension in the mouse. Circulation 101: 923-930, 2000.
10. Chang MW, Barr E, Seltzer J, Jiang YQ, Nabel GJ, Nabel EG, Pharmacek MS, and Leiden JM. Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science 267: 518-522, 1995.
11. Dorai H and Sampath TK. Bone morphogenetic protein-7 modulates genes that maintain the vascular smooth muscle cell phenotype in culture. J Bone Joint Surg 83: S70-S78, 2001.
12. D'Souza FM, Sparks RL, Chen H, Kadowitz PJ, and Jeter JR Jr. Mechanism of eNOS gene transfer inhibition of vascular smooth muscle cell proliferation. Am J Physiol Cell Physiol 284: C191-C199, 2003.
13. Gkonos PJ, Lokeshwar BL, Balkan W, and Roos BA. Neuroendocrine peptides stimulate adenyl cyclase in normal and malignant prostate cell. Regul Pept 22: 43-51, 1995.
14. Gray DW and Marshall I. Human α-calcitonin gene-related peptide stimulates adenylate cyclase and guanylate cyclase and relaxes rat thoracic aorta by releasing nitric oxide. Br J Pharmacol 107: 691-696, 1992.
15. 2+-decrease. J Membr Biol 189: 225-236, 2002.
16. Ignarro LJ, Buga GM, Wood KS, Byrns RE, and Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84: 9265-9269, 1989.
17. Jiang L, Foster FM, Ward P, Tasevski V, Luttrell BM, and Conigrave AD. Extracellular ATP triggers cyclic AMP-dependent differentiation of HL-60 cells. Biochem Biophys Res Commun 232: 626-630, 1997.
18. Katsuki S, Arnold WP, Mittal CK, and Murad F. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerine and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and dydroxylamine. J Cyclic Nucleotide Res 3: 23-35, 1977.
19. Kibbe MR, Li J, Nie S, Watkins SC, Lizonova A, Kovesdi I, Simmons RL, Billiar TR, and Tzeng E. Inducible nitric oxide synthase (iNOS) expression upregulates p21 and inhibits vascular smooth muscle cell proliferation through p42/44 mitogen-activated protein kinase activation and independent of p53 and cyclic guanosine monophosphate. J Vasc Surg 31: 1214-1228, 2000.
20. Li Y, Fiscus RR, Wu J, Yang L, and Wang X. The antiproliferative effects of calcitonin gene-related peptide in different passages of cultured vascular smooth muscle cells. Neuropeptides 31: 503-509, 1997.
21. Lou H, Yang Y, Cote GJ, Berget SM, and Gagel R. An intron splicing enhancer containing 5′ splice site sequence in the human calcitonin/ calcitonin gene-related peptide gene. Mol Cell Biol 15: 7135-7142, 1995.
22. Machado RD, Rudarakanchana N, Atkinsori C, Flanagan JA, Harrison R, Morell NW, and Trembath RC. Functional interaction between BMPR-II and Tctex-1, a light chain of Dynein, is isoform-specific and disrupted by mutations underlying primary pulmonary hypertension. Hum Mol Genet 12: 3277-3286, 2003.
23. McGillis JP, Miller CN, Schneider DB, Fernandez S, and Khopf M. Calcitonin gene-related peptide induces AP-1 activity by a PKA and c-fos-dependent mechanism in pre-B cells. J Neuroimmunol 123: 83-90, 2002.
24. McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, and Foord SM. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393: 333-339, 1998.
25. Miyauchi K, Tadofsu N, Hayashi T, Ono Y, Tokoyoda K, Tsujikasa K, and Yamamoto H. Molecular cloning and characterization of mouse calcitonin gene-related peptide receptor. Neuropeptides 36: 22-33, 2002.
26. Peacock AJ. Primary pulmonary hypertension. Thorax 54: 1107-1118, 1999.
27. Petkov V, Mosgoeller W, Ziesche R, Raderer M, Stiebellehner L, Vonbank K, Funk GC, Hamilton G, Novotny C, Burian B, and Block LH. Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension. J Clin Invest 111: 1339-1346, 2003.
28. Qing X and Keith IM. Targeted blocking of gene expression for CGRP receptors elevates pulmonary artery pressure in hypoxic rats. Am J Physiol Lung Cell Mol Physiol 285: L86-L96, 2003.
29. Qing X, Svaren J, and Keith IM. mRNA expression of novel CGRP 1 receptors and their activity-modifying proteins in hypoxic rat lung. Am J Physiol Lung Cell Mol Physiol 280: L547-L554, 2001.
30. Quirion R and Dumont Y. Multiple receptors for CGRP and related peptides. In: The CGRP Family: Calcitonin Gene-Related Peptide (CGRP), Amylin, and Adrenomedullin, edited by Poyner D, Marshall I, and Brain S. Georgetown, Texas: Eurekah.com/Landes Bioscience, 2000, p. 1-11.
31. Ross R, Atherosclerosis. N Engl J Med 340: 115-126, 1999.
32. Skalli O, Ropraz P, Trzeciak A, Benzonana G, Gillessen D, and Gabbiani G. A monoclonal antibody against α-smooth muscle actin. J Cell Biol 103: 2787-2796, 1986.
33. 1-Adrenergic hypothesis for pulmonary hypertension. Chest 115: 1708-1719, 1999.
34. Tjen-A-Looi S, Ekman R, Lipptori H, Gary J, and Keith I. CGRP and somatostatin modulate chronic hypoxic pulmonary hypertension. Am J Physiol Heart Circ Physiol 263: H681-H690, 1992.
35. Tjen-A-Looi S, Kraiczi H, Ekman R, and Keith IM. Sensory CGRP depletion exacerbates hypoxia-induced pulmonary hypertension in rats. Regul Pept 74: 1-10, 1998.
36. Toyoda K, Faraci FM, Russo AF, Davidson BL, and Heistad DD. Gene transfer of calcitonin gene-related peptide to cerebral arteries: Am J Physiol Heart Circ Physiol 278: H586-H594, 2000.
37. Uddmann R, Edvinsson I, Ekblad E, Hakanson R, and Sundler F. Calcitonin gene-related peptide: perivascular distribution and vasodilatory effects. Regul Pept 15: 1-23, 1986.
38. Wang X, Wang W, Li Y, Bai Y, and Fiscus R. Mechanism of SNAP potentiating antiproliferative effect of calcitonin gene-related peptide in cultured vascular smooth muscle cells. J Mol Cell Cardiol 31: 1599-1606, 1999.
39. Wimalawansa SJ. Calcitonin gene-related peptide and its receptors. Endocr Rev 17: 533-585, 1996.